Related Experiment Videos
[Prostate cancer].
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|May 1, 1984
Summary
Prostate cancer incidence is rising in Japan. Multidisciplinary treatment, including surgery or radiotherapy for early stages, is recommended over estrogen therapy due to cardiovascular risks.
Area of Science:
- Oncology
- Urology
- Cardiovascular Medicine
Context:
- Increasing incidence of prostate cancer in Japan.
- Historical use of antiandrogenic treatments like estrogen therapy and bilateral orchiectomy.
- Rising rates of cardiovascular disease in prostate cancer patients undergoing estrogen treatment.
Purpose:
- To review current treatment strategies for prostate cancer in Japan.
- To highlight the risks associated with estrogen therapy.
- To advocate for multidisciplinary treatment approaches tailored to cancer stage.
Summary:
- Prostate cancer treatment has evolved from hormonal therapies to include radiotherapy, radical prostatectomy, anti-androgens (chlormadinone acetate, cyproterone acetate), and chemotherapy.
- Multidisciplinary care is emphasized, with radical treatments recommended for early-stage, non-metastatic prostate cancer.
- Estrogen therapy, while historically significant, is increasingly scrutinized due to associated cardiovascular risks.
Impact:
- Promotes a shift towards evidence-based, stage-specific treatments for prostate cancer.
- Encourages further research into the cardiovascular effects of prostate cancer therapies.
- Aims to improve patient outcomes through tailored, multidisciplinary care strategies.